Ammonium Chloride → N-(5-((E)-2-((2S,4R)-4-(tert-butyldimethylsilyloxy)-6-oxo-tetrahydro-2H-pyran-2-yl)vinyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide

HRID 2387922노트

반응식

HRID 2387922 반응식
[Br-].[F:2][C:3]1[CH:8]=[CH:7][C:6]([C:9]2[C:14]([CH2:15][P+](C3C=CC=CC=3)(C3C=CC=CC=3)C3C=CC=CC=3)=[C:13]([CH:35]([CH3:37])[CH3:36])[N:12]=[C:11]([N:38]([CH3:43])[S:39]([CH3:42])(=[O:41])=[O:40])[N:10]=2)=[CH:5][CH:4]=1.C[Si](C)(C)N[Si](C)(C)C.[Li].[Si:54]([O:61][C@H:62]1[CH2:67][C:66](=[O:68])[O:65][C@H:64]([CH:69]=O)[CH2:63]1)([C:57]([CH3:60])([CH3:59])[CH3:58])([CH3:56])[CH3:55].[Cl-].[NH4+]>O1CCCC1>[Si:54]([O:61][C@H:62]1[CH2:67][C:66](=[O:68])[O:65][C@H:64](/[CH:69]=[CH:15]/[C:14]2[C:9]([C:6]3[CH:7]=[CH:8][C:3]([F:2])=[CH:4][CH:5]=3)=[N:10][C:11]([N:38]([CH3:43])[S:39]([CH3:42])(=[O:40])=[O:41])=[N:12][C:13]=2[CH:35]([CH3:37])[CH3:36])[CH2:63]1)([C:57]([CH3:60])([CH3:59])[CH3:58])([CH3:56])[CH3:55]

참가 물질

6

반응물 4

HCID 25517Ammonium ChlorideHCID 11239334((4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)methyl)triphenylphosphonium bromideHCID 16113282(2S,4R)-4-(tert-butyldimethylsilyloxy)-6-oxo-tetrahydro-2H-pyran-2-carbaldehydeHCID 57426343Lithium bis(trimethylsilyl)amide

생성물 1

HCID 16113283N-(5-((E)-2-((2S,4R)-4-(tert-butyldimethylsilyloxy)-6-oxo-tetrahydro-2H-pyran-2-yl)vinyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide수율 65.8%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매3회

반응 조건

온도
-30 °C

실험 절차

To a cold (−30° C.), stirred suspension of ((4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)methyl)triphenylphosphonium bromide (376 mg, 0.55 mmol) in dry tetrahydrofuran (10 mL) is added lithium hexamethyldisilazane in THF (0.42 mL of 1.33 M, 0.55 mmol). The reaction mixture is stirred for 30 min, cooled to −78° C., and treated with a solution of (2S,4R)-4-(tert-butyldimethylsilyloxy)-6-oxo-tetrahydro-2H-pyran-2-carbaldehyde (9) (130 mg, 0.50 mmol) in 5 mL of tetrahydrofuran. After 60 min, the solution is warmed to ambient temperature, stirred for 10 min, and treated with saturated ammonium chloride solution. The aqueous phase is extracted with t-BuMeO (2×10 mL), and the combined organic layers dried and concentrated. The residue is purified by silica gel chromatography (elution with t-BuMeO/hexane mixture) to give 190 mg (65%) of N-(5-((E)-2-((2S,4R)-4-(tert-butyldimethylsilyloxy)-6-oxo-tetrahydro-2H-pyran-2-yl)vinyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide (10) as white amorphous solid.

후처리

  1. stirringThe reaction mixture is stirred for 30 min
  2. temperaturecooled to −78° C.
  3. temperaturethe solution is warmed to ambient temperature
  4. stirringstirred for 10 min
  5. extractionThe aqueous phase is extracted with t-BuMeO (2×10 mL)
  6. customthe combined organic layers dried
  7. concentrationconcentrated
  8. customThe residue is purified by silica gel chromatography (
  9. washelution with t-BuMeO/hexane mixture)

출처 및 근거

ORD 기록
ord-f22e5c0b990941b5af9bf251b90c8d58
출처 데이터셋
uspto-grants-2012_09
특허 번호
US08269001B2

반응 노트

불러오는 중…